1. Home
  2. RBA vs BDTX Comparison

RBA vs BDTX Comparison

Compare RBA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RB Global Inc.

RBA

RB Global Inc.

HOLD

Current Price

$83.71

Market Cap

20.0B

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.97

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBA
BDTX
Founded
1958
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.0B
171.9M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
RBA
BDTX
Price
$83.71
$1.97
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$122.20
$9.67
AVG Volume (30 Days)
1.8M
487.0K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
1.18%
N/A
EPS Growth
1.49
130.71
EPS
1.37
N/A
Revenue
$4,590,700,000.00
N/A
Revenue This Year
$4.43
N/A
Revenue Next Year
$6.65
N/A
P/E Ratio
$59.36
N/A
Revenue Growth
7.15
N/A
52 Week Low
$80.66
$1.60
52 Week High
$119.58
$4.94

Technical Indicators

Market Signals
Indicator
RBA
BDTX
Relative Strength Index (RSI) 28.87 41.85
Support Level N/A $1.61
Resistance Level $106.51 $2.28
Average True Range (ATR) 2.16 0.10
MACD 0.44 -0.03
Stochastic Oscillator 8.61 3.75

Price Performance

Historical Comparison
RBA
BDTX

About RBA RB Global Inc.

RB Global has evolved into a leading global marketplace that connects buyers and sellers of commercial assets and vehicles. It is the result of the 2023 combination of Ritchie Bros. and IAA. Ritchie Bros.' roots were as an auctioneer facilitating transactions of commercial, construction, and transportation equipment (excavators, bulldozers, forklifts, and commercial trucks and trailers). However, it has evolved into an omnichannel marketplace. IAA has similar roots, though primarily focused on the salvage auction segment for consumer automobiles. The group provides ancillary services including title processing, transportation/towing, financing, data and appraisal, and so on. Its activities are international, though skewing approximately two-thirds to North America.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: